Biotechnology News

SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of...

EB Development augmente le prix offert dans le cadre de l’offre publique de retrait suivie d’un retrait obligatoire portant sur les actions d’Eurobio Scientific Paris, le 26 octobre 2026 – 18H30 À...

Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support

Press release detailing collaboration between CRISPR experts CasZyme and RNA manufacturer Cirena. Potential breakthroughs in medicine.

Kraig Labs (OTCQB: KBLB) is moving beyond the science of spider silk and into commercialization cycle

REDWOOD CITY, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that its third quarter 2026 financial results will be released on Monday, November 9,...

Please read the announcement in PDF Attachment 2026_25_Share_buyback ...

Longeveron announces updated results of ELPIS II, the Company's trial evaluating its stem cell therapy in HLHS.

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis has received a major shareholder notification from BlackRock, Inc. regarding its holdings in Novonesis. As of October 22, 2026,...

New 23andMe research of nearly 6M people finds 1 in 10 receive medically actionable genetic results, and nearly all choose to learn their health risks.